Workflow
Village Farms(VFF) - 2024 Q4 - Annual Report

Company Performance - Village Farms International, Inc. remains a top three cannabis producer in Canada and was the second fastest growing producer organically year-over-year[393]. - Sales for the year ended December 31, 2024 increased by 50,578,orapproximately1850,578, or approximately 18%, to 336,181 compared to 285,603for2023[400].SalesforVFFreshreached285,603 for 2023[400]. - Sales for VF Fresh reached 169,183, while Cannabis Canada and U.S. Cannabis generated 148,856and148,856 and 17,390 respectively, totaling 336,181fortheyearendedDecember31,2024[429].CanadiancannabisnetsalesfortheyearendedDecember31,2024increasedby336,181 for the year ended December 31, 2024[429]. - Canadian cannabis net sales for the year ended December 31, 2024 increased by 34,826, or 31%, to 148,856from148,856 from 114,030 in 2023[432]. - U.S. Cannabis net sales for the year ended December 31, 2024, decreased by 14% to 17,390from17,390 from 20,330 in 2023, attributed to new restrictions on CBD sales[457]. - Produce sales for the year ended December 31, 2024, increased by 12% to 169,184comparedto169,184 compared to 151,243 in 2023, driven by a 13% increase in pounds sold[471]. Financial Results - The net loss for the year ended December 31, 2024 was 3,181,comparedtonetincomeof3,181, compared to net income of 2,936 in 2023, primarily due to an inventory write-down of 10,436(C10,436 (C15,000)[443]. - Adjusted EBITDA for 2024 decreased by 5,797to5,797 to 1,788 from 7,585in2023[413].ThenetlossattributabletoVillageFarmsInternational,Inc.shareholdersfor2024was7,585 in 2023[413]. - The net loss attributable to Village Farms International, Inc. shareholders for 2024 was 35,850, an increase of 1,052,or31,052, or 3%, compared to 34,798 in 2023[412]. - Loss before taxes and loss from equity method investments for 2024 was 37,305,anincreaseof37,305, an increase of 9,937, or 36%, compared to 27,368in2023[409].AdjustedEBITDAfortheyearendedDecember31,2024was27,368 in 2023[409]. - Adjusted EBITDA for the year ended December 31, 2024 was 7,282, a decrease of 7,482,or517,482, or 51%, compared to 14,764 in 2023, largely due to the inventory impairment charge[445]. Cost and Expenses - Cost of sales for 2024 increased by 52,604,or2252,604, or 22%, to 288,781 from 236,177in2023[401].Selling,generalandadministrativeexpensesfor2024increasedby236,177 in 2023[401]. - Selling, general and administrative expenses for 2024 increased by 5,547 to 71,048,or2171,048, or 21% of sales, from 65,501, or 23% of sales, in 2023[403]. - Gross margin for 2024 decreased by 2,026,or42,026, or 4%, to 47,400 from 49,426in2023[402].Thecompanyincurredexcisetaxof49,426 in 2023[402]. - The company incurred excise tax of 71,953 (C98,442)fortheyearendedDecember31,2024,anincreaseof98,442) for the year ended December 31, 2024, an increase of 13,938 (C20,127),or2420,127), or 24%, compared to 58,015 (C78,315)in2023[433].ImpairmentsandWritedownsGoodwillandintangibleassetimpairmentsfor2024were78,315) in 2023[433]. Impairments and Write-downs - Goodwill and intangible asset impairments for 2024 were 11,939 compared to 14,020in2023[408].InventorywritedownsfortheyearendedDecember31,2024,were14,020 in 2023[408]. - Inventory write-downs for the year ended December 31, 2024, were 11,038 due to older manufactured products requiring higher rework costs than their resale value[537]. - The company reported impairments of 10,039,000forgoodwilland10,039,000 for goodwill and 1,900,000 for intangible assets in 2024, compared to 11,300,000and11,300,000 and 2,720,000 respectively in 2023[514]. Market and Operational Challenges - The company continues to face challenges from unregulated hemp-derived products in the U.S. market, which may impact market share for the CBD industry[393]. - The company is exploring options to sell its Produce assets and has an ongoing sale process for its Monahans greenhouse facility[393]. - The company has material long-term debt and lines of credit that may be affected by rising interest rates, impacting the cost of capital[506]. Strategic Initiatives - The acquisition of Leli Holland was completed in Q4 2024, making it a wholly owned subsidiary, with sales expected to commence in February 2025[386]. - The company plans to continue focusing on market expansion and new product development to drive future growth[429]. - The company plans to consolidate its financial results with a 100% interest in Leli beginning on September 23, 2024[514]. Cash Flow and Liquidity - Cash and cash equivalents as of December 31, 2024 were 24,631,downfrom24,631, down from 35,291 as of December 31, 2023[485]. - Operating activities generated cash flow of 10,348fortheyearendedDecember31,2024,comparedto10,348 for the year ended December 31, 2024, compared to 5,315 for the year ended December 31, 2023[502]. - Cash flows used in investing activities for 2024 were 10,241million,upfrom10,241 million, up from 6,231 million in 2023 and down from 20,889millionin2022,primarilydueto20,889 million in 2022, primarily due to 6,061 million in capital expenditures for Leli and $4,022 million for cannabis operations[503].